Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Anti-PD-L1 (BMS-936559, MDX-1105)
print preview
bookmark
share with colleague
General Information
Company
Bristol-Myers Squibb Co.
Description
Human mAb against PD-L1
Molecular Target
Programmed cell death 1 ligand 1 (CD274 molecule) (PD-L1) (B7-H1)
Mechanism of Action
Antibody
Latest Stage of Development
Phase I
Indication
Solid tumors
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy